Balchem Corporation to Present at the HC Wainwright & Co. 26th Annual Global Investment Conference on September 9, 2024
Balchem (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, has announced its participation in the HC Wainwright & Co. 26th Annual Global Investment Conference on September 9, 2024. The company will be represented by key executives including Ted Harris (Chairman of the Board, President and CEO), Martin Bengtsson (CFO), and Allison Baurichter (Senior Director Investor Relations).
This presentation at a prominent investment conference provides an opportunity for Balchem to showcase its business strategies, financial performance, and growth prospects to potential investors and industry analysts. The event could potentially impact Balchem's stock performance and investor relations.
Balchem (NASDAQ: BCPC), un produttore globale di ingredienti speciali per i mercati della salute e della nutrizione, ha annunciato la sua partecipazione alla 26ª Conferenza Globale di Investimento Annuale HC Wainwright & Co. che si terrà il 9 settembre 2024. L'azienda sarà rappresentata da importanti dirigenti tra cui Ted Harris (Presidente del Consiglio, Presidente e CEO), Martin Bengtsson (CFO) e Allison Baurichter (Direttore Senior delle Relazioni con gli Investitori).
Questa presentazione durante una rinomata conferenza sugli investimenti offre a Balchem l'opportunità di mostrare le proprie strategie aziendali, le performance finanziarie e le prospettive di crescita a potenziali investitori e analisti del settore. L'evento potrebbe avere un impatto sulle performance azionarie di Balchem e sulle relazioni con gli investitori.
Balchem (NASDAQ: BCPC), un fabricante global de ingredientes especiales para los mercados de salud y nutrición, ha anunciado su participación en la 26ª Conferencia Global Anual de Inversiones de HC Wainwright & Co. que se llevará a cabo el 9 de septiembre de 2024. La compañía estará representada por ejecutivos clave, incluyendo a Ted Harris (Presidente de la Junta, Presidente y CEO), Martin Bengtsson (CFO) y Allison Baurichter (Directora Senior de Relaciones con Inversores).
Esta presentación en una prominente conferencia de inversión brinda a Balchem la oportunidad de mostrar sus estrategias comerciales, rendimiento financiero y perspectivas de crecimiento a posibles inversionistas y analistas de la industria. El evento podría impactar potencialmente el rendimiento accionario de Balchem y sus relaciones con los inversionistas.
발켐 (NASDAQ: BCPC)은 건강 및 영양 시장을 위한 글로벌 특수 성분 제조업체로, HC 웨인라이트 & Co. 제26회 연례 글로벌 투자 컨퍼런스에 참여한다고 발표했습니다. 이 행사는 2024년 9월 9일에 열립니다. 회사는 테드 해리스 (이사회 의장, 사장 및 CEO), 마틴 벤크트손 (CFO), 앨리슨 바우리흐터 (투자자 관계 수석 이사) 등 주요 경영진이 참석할 예정입니다.
유명한 투자 컨퍼런스에서의 이 발표는 발켐이 사업 전략, 재무 성과 및 성장 전망을 잠재 투자자 및 산업 분석가에게 보여줄 수 있는 기회를 제공합니다. 이 행사에서 발켐의 주식 성과 및 투자자 관계에 영향을 미칠 수 있습니다.
Balchem (NASDAQ: BCPC), un fabricant mondial d'ingrédients spéciaux pour les marchés de la santé et de la nutrition, a annoncé sa participation à la 26e Conférence Annuelle d'Investissement Mondial HC Wainwright & Co. qui se tiendra le 9 septembre 2024. L'entreprise sera représentée par des cadres clés, notamment Ted Harris (Président du Conseil, Président et CEO), Martin Bengtsson (CFO) et Allison Baurichter (Directrice Senior des Relations Investisseurs).
Cette présentation lors d'une conférence d'investissement de premier plan offre à Balchem l'opportunité de mettre en avant ses stratégies commerciales, ses performances financières et ses perspectives de croissance auprès de potentiels investisseurs et analystes du secteur. L'événement pourrait avoir un impact sur la performance boursière de Balchem et sur les relations avec les investisseurs.
Balchem (NASDAQ: BCPC), ein globaler Hersteller von Spezialzutaten für Gesundheits- und Ernährungsmärkte, hat seine Teilnahme an der 26. jährlichen globalen Investorenkonferenz von HC Wainwright & Co. am 9. September 2024 bekannt gegeben. Das Unternehmen wird von wichtigen Führungskräften vertreten, darunter Ted Harris (Vorsitzender des Vorstands, Präsident und CEO), Martin Bengtsson (CFO) und Allison Baurichter (Senior Director Investor Relations).
Diese Präsentation auf einer bedeutenden Investorenkonferenz bietet Balchem die Möglichkeit, seine Geschäftsstrategien, finanziellen Leistungen und Wachstumsaussichten potenziellen Investoren und Branchenanalysten vorzustellen. Die Veranstaltung könnte potenziell die Aktienentwicklung von Balchem und die Beziehungen zu den Investoren beeinflussen.
- None.
- None.
MONTVALE, N.J., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the HC Wainwright & Co. 26th Annual Global Investment Conference on September 9, 2024. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will present at the conference.
About Balchem Corporation
Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.
| Contact: | Jacqueline Yarmolowicz Balchem Corporation (Telephone: 845-326-5600) | |
FAQ
When is Balchem (BCPC) presenting at the HC Wainwright & Co. Global Investment Conference?
Who will be representing Balchem (BCPC) at the investment conference?
What is the significance of Balchem (BCPC) presenting at the HC Wainwright & Co. conference?
What markets does Balchem (BCPC) serve as a specialty ingredient manufacturer?
